A leading pharmaceutical company faced significant challenges in protecting highly sensitive research data, including drug formulas and patient trial information, as employees increasingly adopted generative AI tools for research and analysis.
Explore our resources for actionable insights on data security and management
A leading pharmaceutical company faced significant challenges in protecting highly sensitive research data, including drug formulas and patient trial information, as employees increasingly adopted generative AI tools for research and analysis.
In the fast-paced pharmaceutical industry, the ability to analyze vast datasets quickly is crucial for drug discovery and development. Generative AI tools offered the potential to accelerate these processes significantly. However, the company’s security team became increasingly concerned about the risk of sensitive information being inadvertently or intentionally shared with public AI models. Researchers were using these tools to summarize research papers, brainstorm new drug targets, and even analyze preliminary trial results, raising fears that confidential formulas, experimental data, and patient-identifiable information could be exposed. Existing data loss prevention (DLP) solutions were not designed to monitor interactions with generative AI platforms, leaving a significant security gap. The challenge was to enable the innovative use of AI while maintaining strict data confidentiality and adhering to stringent regulatory requirements like HIPAA.
The pharmaceutical company implemented Fasoo AI-Radar DLP (AI-R DLP) to gain visibility and control over how generative AI was being used within the organization. AI-R DLP was deployed to monitor data being input into various generative AI services. By leveraging its pattern-matching and AI-powered content analysis capabilities, the solution could accurately identify sensitive information such as drug compound names, chemical structures (even within text prompts), clinical trial codes, and keywords associated with confidential projects. Administrators configured detailed blocking policies within AI-R DLP. These policies included:
The implementation of Fasoo AI-Radar DLP yielded significant benefits for the pharmaceutical company:
Join us to learn how to protect your unstructured data at rest, in transit, and in use in today’s AI-powered, hybrid workd environment.